In this review, we focus on the therapeutic potential and underlying work of action of the different PPAR isoforms on corneal diseases, including corneal wound healing, corneal inflammation, fibrosis, neovascularisation, corneal nerve regeneration, and dry eye disease. This evidence concerns the gene PPARA and corneal disorder.